Cargando…
Formulation strategies in immunotherapeutic pharmaceutical products
Development of immunologic-based biopharmaceutical products have strikingly increased in recent years and have made evident contributions to human health. Antibodies are the leading entity in immunotherapy, while chimeric antigen receptor T cells therapies are the advent of a novel strategy in this...
Autores principales: | Zhang, Yajie, Williams III, Robert O, Tucker, Haley Oana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360519/ https://www.ncbi.nlm.nih.gov/pubmed/32728530 http://dx.doi.org/10.5306/wjco.v11.i5.275 |
Ejemplares similares
-
EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges
por: Chaudry, M A, et al.
Publicado: (2007) -
Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
por: Asghar, Kashif, et al.
Publicado: (2017) -
Immune microenvironment of medulloblastoma: The association between its molecular subgroups and potential targeted immunotherapeutic receptors
por: Kurdi, Maher, et al.
Publicado: (2023) -
Microbial alginate production, modification and its applications
por: Hay, Iain D, et al.
Publicado: (2013) -
Maintenance and assessment of cell viability in formulation of non‐sporulating bacterial inoculants
por: Berninger, Teresa, et al.
Publicado: (2017)